Document:

Tissue Recovery Agreement

 EXHIBIT 10.1 
  
 CONFIDENTIAL TREATMENT REQUESTED PURSUANT TO RULE 24B-2 
  
 Certain portions, indicated by [*****], of this exhibit have been omitted pursuant to Rule 24b-2 of the Securities Act of
1934. The omitted materials have been filed separately with Securities and Exchange Commission. 
  
 TISSUE RECOVERY AGREEMENT 
  
 THIS TISSUE RECOVERY AGREEMENT (this “Agreement”), effective on this 21st day of January, 2005 (“Effective Date”), is by and between Regeneration Technologies, Inc., a Delaware corporation having its principal place of
business at 11621 Research Circle, Alachua, Florida (“RTI”), and Southeast Tissue Alliance, Inc., a Florida not-for-profit corporation having its principal place of business at 6241 NW 23rd Street, Suite 400, Gainesville, Florida
(“SETA”). 
  
 WITNESSETH 
  
 WHEREAS, RTI and SETA were parties to that certain agreement entitled, the
“Tissue Recovery Agreement” made and entered into by the parties effective as April 15, 1999, and as amended by letters dated January 19, 2001, and December 19, 2001; (the “Previous Agreement”) attached hereto as Exhibit
“A”; and 
  
 WHEREAS, the parties wish to replace the
Previous Agreement with this Agreement; and 
  
 WHEREAS, RTI
recovers and processes human donor tissue and has arrangements with third parties to distribute the resulting allograft tissue for implant surgeries throughout the world; and 

 WHEREAS, SETA desires to recover and provide human tissue to RTI for processing allograft tissue and for
conducting research, and both parties desire to cooperate to increase the amount of human tissue available for the production by RTI and distribution of allograft tissue. 
  
 NOW, THEREFORE, in view of the representations made above and in consideration of the terms and conditions set forth below,
the parties agree as follows: 
  

 2 

 ARTICLE I -General Obligations 
  
 1.1 Upon the effective date of this Agreement the parties acknowledge that the Previous Agreement has been terminated,
except that indemnification provisions of the Previous Agreement shall survive its termination. 
  
 1.2 As consideration for RTI entering into this Agreement, for the term of this Agreement SETA shall: 
  
 a. Use reasonable efforts to maximize the number and amount of human tissue
within RTI’s Donor Acceptance Criteria and Standard Operating Procedures (“DAC/SOP”) for tissues described in Exhibit “C” (Exclusive Tissues”) and that SETA recovers from its current recovery agreements with the
hospitals, medical examiners and funeral homes listed in Exhibit “B” (hereinafter “Exclusive Territories”) solely and exclusively to RTI, at the “Recovery Fees” as set forth in Exhibit “C” and as such fees may
be amended on an annual basis in accordance with Article 1.8 of this Agreement; 
  
 b. have the right to supply the remaining 100% of all tissue recovered by SETA outside the Exclusive Territories to the processor of SETA’s choice;  
  
 c. Notwithstanding SETA’s obligation to supply Exclusive Tissue
recovered in the Exclusive Territories, SETA may supply such Exclusive Tissue to another processor: 
  
 (1) selected by a donor hospital in the event that a hospital requests in writing that the tissue be processed by an entity which supplies the resulting
allograft tissue for implant surgeries to the donor hospital; or 
  
 (2) if the tissue is deemed rejected by RTI because it is out of their medical criteria. 
  

 3 

 (3) Provided however, that SETA shall do nothing to encourage or otherwise cause any donor, any donor
family, or any donor hospital to select a tissue processor other than RTI, except as specifically required by law. Provided further that SETA shall reimburse RTI for all shipping and storage costs incurred by RTI for tissue which is sent to a
processor other than RTI; 
  
 d. diligently endeavor to provide
human donor tissues to RTI which meet or exceed RTI’s DAC/SOP requirements for quality control, quality assurance, and other specifications set forth in RTI’s DAC/SOP as are currently in effect; RTI may modify the DAC/SOPs after reasonable
written notice to SETA; 
  
 e. use reasonable efforts to maintain
and expand its tissue recovery efforts in the Exclusive Territories and not enter or attempt to enter into tissue recovery agreements with any source of human donor tissue with which RTI currently engages in donor recovery activities which are set
forth in Exhibit “D”, without the prior written consent of RTI and such consent shall not be unreasonably withheld, provided however, SETA shall be permitted to enter into agreements with any source of human donor tissue for the purpose of
obtaining tissue to be used solely for research as long as all tissue which is suitable for processing is made available to RTI under the applicable terms of this agreement; 
  
 f. not solicit or attempt to employ any person who is at the time an employee or agent of RTI or who has been during the
previous one year period, without express written approval of RTI; and 
  
 g. not interfere with or assert any rights with respect to RTI’s past, current or future arrangements or contracts with any RTI Distributors. 
  
 1.3 In the event RTI determines that any Exclusive Tissue to be “out of criteria” according to RTI’s then current DAC/SOP, such tissue
shall no longer be subject to this Agreement. 
  

 4 

 1.4 On or about the effective date herein, SETA shall provide RTI with a copy of SETA’s
donor-related recovery and screening forms and the parties will work together to make form related changes as required by RTI. 
  
 1.5 RTI and SETA shall be given reasonable access on a semi-annual basis to inspect such books and records of SETA and RTI, respectively, necessary to
verify adherence with the terms of this agreement. 
  
 1.6 As
consideration for SETA entering into this Agreement with RTI, RTI shall: 
  
 a. use commercially reasonable efforts to assure that hospitals that are sources of donor tissue recovered by SETA have access to allograft tissue processed by RTI on a commercially reasonable basis. SETA acknowledges
that RTI processes tissue that is distributed through a limited number of distributors, including Medtronic Sofamor Danek USA, Inc., Stryker Endoscopy, Inc., and Exactech, Inc., and such distributors may be changed from time to time (the “RTI
Distributors”); 
  
 b. not directly or indirectly, or through
any subsidiary, affiliate, or joint venture: 
  
 (1) interfere
with SETA’s contractual tissue recovery operations in the hospitals, medical examiners or funeral homes with which SETA has a contractual or ongoing business relationship for donor recovery services, without the prior written consent of SETA,
and such consent shall not be unreasonably withheld; 
  
 (2)
recover tissue or contract with any other recovery agency to recover tissue in the Exclusive Territories without the prior written consent of SETA, and such consent shall not be unreasonably withheld; 
  

 5 

 (3) distribute or otherwise transfer any unprocessed tissue received from SETA to any third party whose
purpose is to process and distribute such tissue, provided however RTI shall be permitted to distribute tissue which is in excess of its processing needs. 
  
 (4) do anything to encourage or otherwise cause any hospital or other recovery source or agency in the Exclusive Territory to select a tissue donor
recovery agency other than SETA; 
  
 (5) solicit for employment,
or attempt to employ, any person who is at the time an employee or agent of SETA or who has been during the previous one year period without the express written approval of SETA; 
  
 (6) nothing herein, however, shall otherwise prevent RTI from obtaining tissue from any other source outside the Exclusive
Territories. 
  
 c. for the term of this Agreement, accept all
Exclusive Tissue and reimburse SETA for tissue provided by SETA meeting RTI’s DAC/SOP, under the terms and conditions set forth herein; and 
  
 d. RTI agrees that any and all wholly-owned subsidiaries of RTI, whether or not such subsidiary exists today or is to be formed or acquired in the future,
shall guarantee the payment obligations of RTI as set forth in Article III herein, and RTI shall, cause such subsidiaries to execute any and all documents necessary to effect the intent of such agreement to guarantee such payment obligation;
provided however, such guarantee by such subsidiary shall continue only during the time period that such subsidiary is wholly owned directly or indirectly by RTI. 
  
 e. in the event that the donor family specifically requests that the tissue be processed by a not-for-profit entity, in
which case RTI shall send the Exclusive Tissue to a not-for-profit processor selected by RTI. 
  

 6 

 1.7 In the event that RTI desires to receive any tissues from SETA, which are not listed on Exhibit C,
RTI shall provide SETA with thirty (30) days advance notice of such tissue need. 
  
 1.8 On or about April 1, 2005 and on or about April 1 of each subsequent year the Recovery Fees set forth on Exhibit C shall be adjusted upward based on the percentage change in the Consumer Price Index for medical
care services (U.S. city average, all urban consumers, medical care services, published by the U.S. Bureau of Labor Statistics or its successors) (“CPI-H”) for the immediately preceding year. Specifically, the percentage change shall be
the percentage determined by dividing the change in the (CPI-H) for the immediately preceding 12 months ending on March 31st by the (CPI-H) as of March 31st at the beginning of the period. The following hypothetical example illustrates the
computation of the percentage change to be determined to be effective April 1, 2005. 
  

				
	 CPI for March 2005
	  	136.0	 
		
	 Less: CPI for March 2004
	  	129.9	 
		
	 Equals index point change
	  	6.1	 
		
	 Divided by March 2004 CPI
	  	129.9	 
		
	 Equals
	  	0.047	 
		
	 Results multiplied by 100
	  	0.047	 x 100
		
	 Equals percent change
	  	4.7	 

  
 1.9 Notwithstanding
the above annual recovery fee increases, in the event SETA incurs an unforeseen extraordinary increase in third party expenses, the parties agree to negotiate in good faith reimbursement of such expenses as long as they are in effect. 
  

 7 

 ARTICLE II -Acceptance and Rejection of Tissues 
  
 2.1 RTI shall accept tissue from SETA if such tissues meet or exceed the
requirements set forth in RTI’s DAC/SOPs, and in the event that any tissues provided or expected to be provided to RTI by SETA do not meet such requirements, as determined by RTI, and RTI rejects such tissue within thirty (30) days of SETA
providing all necessary information to RTI for RTI to make a medical determination whether to accept or reject the tissue, SETA shall have the right to make such tissues available to any third party. 
  
 2.2 In the event that RTI rejects any tissue supplied by SETA due to a
failure to meet the requirements set forth in RTI’s DAC/SOPs, RTI shall notify SETA in writing of such rejection(s) within thirty (30) days of SETA providing all necessary information to RTI for RTI to make a medical determination whether to
accept or reject the tissue, and state the reason(s) for such rejection(s). RTI shall retain such tissue for a minimum of thirty (30) days prior to any disposition of rejected tissues. After the expiration of thirty (30) days following SETA’s
receipt of RTI’s notice of rejection RTI shall destroy such tissue or designate said tissue for research if applicable. 
  
 ARTICLE III -Fees and Payments 
  
 3.1 Recovery Fees for Exclusive Tissue payable by RTI to SETA for amounts due under this Agreement for recovery services shall be based upon the fees then
currently in effect set forth in Exhibit C and paragraph 1.8, and such payment shall be made in accordance with this Article 3.1. 
  
 a. Invoices are payable weekly within thirty (30) days of the invoice date. Rejection credits will be deducted from the second weekly check of each month.

  

 8 

 b. SETA shall be responsible for and shall pay all shipping and packaging costs associated with providing
donors or donor tissue to RTI under this Agreement. 
  
 c. SETA
shall provide all documentation to RTI necessary to perform the master donor chart review and medical director rejection or release. Both RTI and SETA shall use their best efforts to obtain medical releases promptly. 
  
 d. Payments due on invoices commencing on the Effective Date of this
Agreement to either party under this Article III which are more than thirty (30) days past due shall bear interest at a rate equal to Bank of America Prime rate plus 2%. 
  
 ARTICLE IV –Term and Termination 
  
 4.1 The term of this Agreement shall be for a period of five (5) years commencing with the effective date set forth above.

  
 4.2 Either party hereto may terminate this Agreement early:
(a) due to a material breach by the other party of any of its obligations or covenants hereunder upon thirty (30) calendar days written notice to the breaching party of its intent to so terminate if such breaching party fails to remedy such breach
within such thirty (30) calendar days, or if such breach cannot be remedied within such thirty (30) calendar days, only if such breaching party has not undertaken good faith efforts to remedy such breach; (b) immediately upon the insolvency or
filing for bankruptcy by the other party; or (c) upon the mutual written consent of the parties. 
  
 ARTICLE V – Warranty, Indemnity and Other Representations 
  
 5.1 Both parties represent and warrant that the rights granted herein do not violate any rights previously granted by either party to any third party.

  
 5.2 SETA warrants that it will carry out its obligations under
this Agreement in full compliance with all applicable federal, state and local laws, rules and regulations relating thereto 

  

 9 

 
within the United States, including, but not limited to, the regulations interpreting the Health Insurance Portability and Accountability Act (45 CFR
164.512(h)), regulations promulgated by the Food and Drug Administration and Centers for Medicare and Medicaid Services, the rules issued by the Joint Commission for Accreditation of Healthcare Organizations, the Federal Food, Drug and Cosmetic Act
(including Good Tissue Practices Regulations), the National Organ Transplant Act, FDA tissue regulations, and standards of the American Association of Tissue Banks. 
  
 5.3 SETA warrants to RTI that all tissues are screened according to local, state, federal regulations in force at the time
of recovery. 
  
 5.4 SETA shall at all times during the term of
this Agreement and thereafter, indemnify, defend and hold RTI, RTI Affiliates (as hereinafter defined), or any of its assigns, harmless against all claims and expenses, including legal expenses and reasonable attorney fees, arising out of any other
claims, proceeding, demand, expense, loss, and liability of any kind whatsoever including any breach of its obligations hereunder (collectively, “RTI Losses”) resulting from the activities of SETA under this Agreement, except where such
RTI Losses result solely from RTI’s gross negligence or willful misconduct. As used in this Agreement, “RTI Affiliates” shall mean RTI’s directors, officers, agents and employees. Notwithstanding the above, RTI, at all times,
reserves the right to retain counsel of its own, at its own expense, to defend RTI’s interests. This Article 5.4 shall survive the termination of this Agreement. 
  
 5.5 RTI shall at all times during the term of this Agreement and thereafter, indemnify, defend and hold SETA, SETA
Affiliates (as hereinafter defined), or any of its assigns, harmless against all claims and expenses, including legal expenses and reasonable attorney fees, arising out of any other claims, proceeding, demand, expense, loss, and liability of any
kind whatsoever 

  

 10 

 
including any breach of its obligations hereunder (collectively, “SETA Losses”) resulting from the activities of RTI under this Agreement, except
where such SETA Losses result solely from SETA’s gross negligence or willful misconduct. As used in this Agreement, “SETA Affiliates” shall mean SETA’s directors, officers, agents and employees. Notwithstanding the above, SETA at
all times reserves the right to retain counsel of its own, at its own expense, to defend SETA’s interests. This Article 5.5 shall survive the termination of this Agreement. 
  
 5.6 Each party warrants that it now maintains and will continue to maintain liability insurance coverage in an amount of at
least one million dollars ($1,000,000) per occurrence and three million dollars ($3,000,000) in the aggregate. Each party shall provide the other party with at least thirty (30) days written notice of any change or cancellation of such insurance
coverage. 
  
 5.7 SETA represents that for the term of this
Agreement, SETA maintains current licensure/registration with applicable state and federal agencies, and is either Accredited by the American Association of Tissue Banks (AATB) or meets AATB Standards. Evidence of current licensure/registration will
be provided upon request. 
  
 ARTICLE VI - Assignment

  
 6.1 This Agreement has been entered into by RTI and SETA
in reliance upon the particular qualifications of each party and is personal to each party. Neither this Agreement, nor any rights or obligations hereunder, may be assigned, pledged or encumbered by SETA or RTI without the express prior written
approval of the other party, provided that such approval shall not be unreasonably withheld. RTI may assign this Agreement to a third party without the prior consent of SETA provided that (i) such third party provides in written form to SETA
reasonably satisfactory evidence that the third party is of equal or better financial condition than RTI, and (ii) such third party agrees to provide such written assurances to SETA and agrees to execute such agreements to meet the obligations of
RTI under this Agreement. 
  

 11 

 ARTICLE VII - Miscellaneous 
  
 7.1 A waiver of any specific breach of any provision of this Agreement shall not be construed as a continuing waiver of
other breaches of the same or other provisions of this Agreement. 
  
 7.2 The right of either party to terminate under the provisions of this Agreement shall not be an exclusive remedy, and either party shall be entitled, if the circumstances warrant, alternatively or cumulatively, to damages for breach of
this Agreement, and/or to an order requiring performance of the obligations of this Agreement. 
  
 7.3 Nothing herein shall be deemed to create an agency, joint venture or partnership relationship between the parties hereto. 
  
 7.4 This Agreement shall be interpreted and construed in accordance with the laws of the State of Florida. 
  
 a. Any dispute among the parties arising out of or in connection with this
Agreement or any other agreement, instrument or other document delivered pursuant to this Agreement, or any alleged breach hereof or thereof (other than a dispute in respect of which there is a reasonable likelihood of irreparable harm and as to
which a party may seek a temporary restraining order or injunctive relief) shall be submitted for discussion and possible resolution by senior officers of each such party. 
  
 b. if within a period of 15 days after submission of a matter in accordance with clause (a) hereof the respective senior
officers are unable to agree upon a resolution, either party may within 15 days after the aforesaid 15-day period elect to require the submission of the dispute to mediation in Gainesville, Florida or another location as agreed by the parties using
a 

  

 12 

 
mediator acceptable to both parties and if the parties cannot agree on a mediator then the parties will agree to utilize a mediator from the firm of
Upchurch, Watson, White and Max in Daytona Beach, Florida. The parties shall bear their respective costs incurred in connections with this procedure including the fees and expenses of the mediator. 
  
 c. If the dispute cannot be resolved through mediation within ninety (90)
days after submission of a matter to mediation, and the liability or damages at issue in the dispute is less than or equal to [******], the parties agree that such dispute will be resolved by binding private arbitration under rules administered by
the American Arbitration Association. Unless otherwise agreed to in writing by the parties, such arbitration shall be held in Gainesville, Florida and will consist of a single arbitrator agreed to by the parties, or if the parties cannot agree, an
arbitrator shall be assigned by AAA. Judgment upon any arbitration award may be entered in any court of competent jurisdiction. 
  
 d. If the dispute cannot be resolved through mediation within ninety (90) days after submission of a matter to mediation, and the liability or damages at
issue in the dispute is greater than [*****], either party may file an action in court in accordance with Article 7.4 e. Any filings containing confidential proprietary information of either party shall be filed under seal and the parties agree to
negotiate a protective order as to all proprietary confidential information. 
  
 e. This Agreement shall be interpreted and construed in accordance with the laws of the State of Florida and the parties agree that: a) they are subject to the jurisdiction of the State and Federal courts located
within the State of Florida; b) the exclusive venue for actions seeking relief under this Agreement shall be the Circuit Court for Alachua County, Florida or the United States District Court having jurisdiction over Alachua County, Florida; and c)
in any 

  

 13 

 
action brought to enforce or interpret the rights or obligations relating to this Agreement the prevailing party in such action shall be entitled to an award
of it’s reasonable attorney’s fees and costs including presuit and appellate attorney fees and cost from the non-prevailing party. 
  
 f. The terms of the Article 7.4 shall survive the termination of this Agreement. 
  
 7.5 This Agreement may be amended only by a written document signed by authorized representatives of both parties.

  
 7.6 Each party hereto agrees to execute, acknowledge and
deliver all such further instruments as may be necessary or appropriate to carry out the intent and purposes of this Agreement. This Agreement shall be binding upon and inure to the benefit of the respective parties hereto, their heirs, legal
representatives, successors and permitted assigns. 
  
 7.7 The
headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. 
  
 7.8 Should any part or provision of this Agreement be held unenforceable or in conflict with the law of any jurisdiction, the validity of the remaining
parts or provisions shall not be affected by such holding. In the event a part or provision of this Agreement is held unenforceable or in conflict with the law affecting consideration to either party, the parties agree to negotiate in good faith to
amend such part or provision in a manner consistent with the intention of the parties as expressed in this Agreement. 
  
 7.9 Neither party shall be responsible or liable to the other party for nonperformance or delay in performance of any terms or conditions of this
Agreement due to acts or occurrences beyond the control of the non-performing or delayed party including, but not limited to, acts of God, acts of government, terrorism, wars, riots, strikes or other labor disputes, shortages of labor 

  

 14 

 
or materials, fires and floods, provided the non-performing or delayed party provides to the other party written notice of the existence and the reason for
such nonperformance or delay. The nonperformance or delay by either party in excess of one hundred eighty (180) days shall constitute cause for termination of this Agreement with such notice given in writing by one party to the other. 
  
 7.10 Any and all notices or other communications required or permitted by
this Agreement or by law to be served on or given to either party by the other party shall be in writing and delivered or sent to: 
  

			
	RTI:	  	Brian K. Hutchison, President and CEO
	 	  	Regeneration Technologies, Inc.
	 	  	Post Office Box 2650
	 	  	11621 Research Circle
	 	  	Alachua, FL 32615
		
	Copy:	  	Jeffrey M. Schumm, General Counsel
	 	  	Regeneration Technologies, Inc.
	 	  	Post Office Box 2650
	 	  	11621 Research Circle
	 	  	Alachua, FL 32615
		
	SETA:	  	Lawrence A. Hopkins, President and CEO
	 	  	Southeast Tissue Alliance, Inc.
	 	  	6241 NW 23rd Street, Suite 400
	 	  	Gainesville, FL 32653
		
	Copy:	  	Janet Ailstock, P.A.
	 	  	2615 NW 5th Place
	 	  	Gainesville, FL 32607

  
 7.11 Each party may
change its address for purposes of this Agreement by written notice to the other party. All notices or other communications shall be deemed duly served and given on the date when personally delivered to the party to whom it is directed, when sent by
FedEx or other reasonably similar courier, or when deposited in the United States mail, first class, postage prepaid, and addressed to the party at the address in Article 7.10 herein. 
  

 15 

 7.12 Absent express, prior written permission by both parties, the parties to this Agreement, their
officers, directors, attorneys, employees and agents shall strictly maintain the confidentiality of, and shall not disclose to any third party, the terms of this Agreement except, the parties and their officers, directors, attorneys, employees and
agents shall also maintain the confidentiality of any personal data of donors, any processes, patent applications, technical, financial or business information, whether general or otherwise, which is disclosed to it by the other party and which is
normally treated as confidential by such other party. The parties shall use their best efforts to assure compliance with the requirements of this Article 7.12 by their officers, directors, attorneys, employees and agents. This Article 7.12 shall
survive the termination of this Agreement. 
  
 7.13 This Agreement
shall be executed by each party in duplicate originals, each of which shall be deemed an original, but both originals together shall constitute only one and the same instrument. 
  

 16 

 IN WITNESS WHEREOF, the parties have executed this Agreement in duplicate on the signature page hereof.

  

			
	Regeneration Technologies, Inc.
		
	By:	 	  

	Name/Title:	 	 Brian K. Hutchison, Chairman,
 President and
CEO

	Date:	 	  

	
	Southeast Tissue Alliance, Inc.
		
	By:	 	  

	Name/Title:	 	Lawrence A. Hopkins, President
	Date:	 	  

  

 17 

 Exhibit A 
  
 Previous Agreements 
  
 Tissue Recovery Agreement made and entered into by the parties effective as April 15, 1999, and as amended by letters dated January 19, 2001, and
December 19, 2001; (the “Previous Agreement”) attached hereto as Exhibit “A”. 
  

 18 

 Exhibit B 
 SETA Exclusive Territories 
 Hospitals, Medical Examiners and Funeral Homes 
  

	A.	Florida Hospitals 

  

			
	1.	 	[*****]
	2.	 	[*****]
	3.	 	[*****]
	4.	 	[*****]
	5.	 	[*****]
	6.	 	[*****]
	7.	 	[*****]
	8.	 	[*****]
	9.	 	[*****]
	10.	 	[*****]
	11.	 	[*****]
	12.	 	[*****]
	13.	 	[*****]
	14.	 	[*****]
	15.	 	[*****]
	16.	 	[*****]
	17.	 	[*****]
	18.	 	[*****]
	19.	 	[*****]
	20.	 	[*****]
	21.	 	[*****]
	22.	 	[*****]
	23.	 	[*****]
	24.	 	[*****]
	25.	 	[*****]
	26.	 	[*****]
	27.	 	[*****]
	28.	 	[*****]
	29.	 	[*****]
	30.	 	[*****]
	31.	 	[*****]
	32.	 	[*****]
	33.	 	[*****]
	34.	 	[*****]
	35.	 	[*****]
	36.	 	[*****]
	37.	 	[*****]
	38.	 	[*****]
	39.	 	[*****]

  

 19 

			
	40.	 	[*****]
	41.	 	[*****]
	42.	 	[*****]
	43.	 	[*****]
	44.	 	[*****]
	45.	 	[*****]
	46.	 	[*****]
	47.	 	[*****]
	48.	 	[*****]
	49.	 	[*****]
	50.	 	[*****]
	51.	 	[*****]
	52.	 	[*****]
	53.	 	[*****]
	54.	 	[*****]
	55.	 	[*****]
	56.	 	[*****]
	57.	 	[*****]
	58.	 	[*****]
	59.	 	[*****]
	60.	 	[*****]
	61.	 	[*****]
	62.	 	[*****]
	63.	 	[*****]
	64.	 	[*****]
	65.	 	[*****]
	66.	 	[*****]
	67.	 	[*****]
	68.	 	[*****]
	69.	 	[*****]
	70.	 	[*****]
	71.	 	[*****]

  
 Medical Examiners: 
  

			
	1.	 	[*****]
	2.	 	[*****]
	3.	 	[*****]
	4.	 	[*****]
	5.	 	[*****]

  

 20 

 Funeral Homes: 
  

			
	1.	 	[*****]
	2.	 	[*****]
	3.	 	[*****]
	4.	 	[*****]
	5.	 	[*****]
	6.	 	[*****]
	7.	 	[*****]
	8.	 	[*****]
	9.	 	[*****]
	10.	 	[*****]
	11.	 	[*****]
	12.	 	[*****]
	13.	 	[*****]
	14.	 	[*****]
	15.	 	[*****]
	16.	 	[*****]
	17.	 	[*****]
	18.	 	[*****]
	19.	 	[*****]
	20.	 	[*****]
	21.	 	[*****]
	22.	 	[*****]
	23.	 	[*****]
	24.	 	[*****]
	25.	 	[*****]
	26.	 	[*****]
	27.	 	[*****]
	28.	 	[*****]
	29.	 	[*****]
	30.	 	[*****]
	31.	 	[*****]
	32.	 	[*****]
	33.	 	[*****]
	34.	 	[*****]
	35.	 	[*****]
	36.	 	[*****]
	37.	 	[*****]
	38.	 	[*****]

  

 21 

 Exhibit C 
 Reimbursement Schedule and Terms 
  

 22 

 Exhibit D 
 RTI Donor Recovery Areas 
  

	
	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

	 [*****]

  

 23Settlement Agreement, executed on March 21, 2005

 Exhibit 10.1 
  
 SETTLEMENT AGREEMENT 
  

This Settlement Agreement (this “Agreement”) is entered into as of this 16th day of March 2005 (the “Effective Date”) by and between Computer Associates International, Inc., on the one hand, and Quest Software, Inc., Michael
J. Friel (“Friel”), Robert M. Mackowiak (“Mackowiak”), Elizabeth W. Wahlgren (“Wahlgren”), Frank L. Bisotti (“Bisotti”), and Debra A. Jenson (“Jenson”), on the other hand. Quest Software, Friel,
Mackowiak, Wahlgren, Bisotti, and Jenson are referred to collectively in this Agreement as the “Defendants.” Computer Associates and Defendants are referred to collectively in this Agreement as the “Parties” and individually as a
“Party.” 
  
 RECITALS 
  
 A. Computer Associates is in the business of developing, manufacturing, and
licensing certain proprietary computer software programs. Computer Associates asserts that it is the owner of the Enterprise Database Administration software program and copyrights and trade secrets therein, all of which are defined below.

  
 B. Quest Software is in the business of developing,
manufacturing, and licensing certain proprietary computer software programs, including database administration programs that function across several database platforms. 
  
 C. Friel is, and Mackowiak, Wahlgren, Bisotti, and Jenson were, at the relevant times, employees of Quest Software.

  
 D. On July 2, 2002, Computer Associates filed a lawsuit
in the United States District Court for the Northern District of Illinois asserting claims for copyright infringement and trade secret misappropriation against Quest Software, Friel, Mackowiak, Wahlgren, and Jenson. The lawsuit is entitled
Computer Associates International, Inc. v. Quest Software, Inc. et al., Case No. 02 C 4721 (the “Lawsuit”). In the Lawsuit, Computer Associates sought damages and an injunction. 
  
 E. On May 11, 2003, Computer Associates amended its complaint in the Lawsuit
to add Bisotti as a defendant on the copyright infringement and trade secret misappropriation claims, and adding breach of contract claims against Jenson, Wahlgren, and Bisotti. 
  
 F. On October 16, 2003, Computer Associates filed a Motion for Preliminary Injunction in the Lawsuit. 
  
 G. On January 16, 2004, Defendants filed a Counterclaim against Computer
Associates in the Lawsuit seeking a declaratory judgment that Computer Associates’ copyrights were invalid and unenforceable. Defendants also asserted affirmative defenses of unclean hands, license, fraud on the Copyright Office and copyright
misuse. 

 H. On June 24, 2004, the District Court granted Computer Associates’ Motion for Preliminary
Injunction against the Defendants. 
  
 I. On August 3, 2004, the
District Court entered an order enjoining Defendants from, among other things, using or licensing the Quest Central for DB2 product (as defined below). 
  
 J. On August 26, 2004, Defendants filed an appeal with the United States Court of Appeals for the Seventh Circuit seeking to dissolve the injunction (the
“Appeal”). The Appeal is still pending. 
  
 K. The
Parties desire to dismiss the Lawsuit and the Appeal and to resolve, settle, and compromise the Lawsuit and the Appeal. 
  
 L. In settlement of this matter, Computer Associates agrees to grant Quest Software a license pursuant to the terms of the License Agreement (attached as
Exhibit A), which is concurrently entered into by Computer Associates and Quest Software, in exchange for a lump sum of $16 million dollars from Quest Software, a $25,000.00 payment from Jenson and royalty payments pursuant to the terms of the
License Agreement. 
  
 M. In settlement of this matter, Friel,
Mackowiak, Wahlgren, Bisotti and Jenson agree to a permanent prohibition against making, using, copying, distributing, marketing, selling, or offering to sell EDBA, and otherwise agree to permanently refrain from any acts that would infringe the
asserted CA Copyrights or constitute a misappropriation of the asserted CA Trade Secrets, except as allowed under the License Agreement. 
  
 N. The Parties desire to enter into this Agreement without making any admissions regarding their respective contentions as to issues involved in the
Lawsuit. Defendants specifically deny any and all liability for claims asserted by Computer Associates in the Lawsuit. Computer Associates specifically denies any and all liability for counterclaims asserted by Defendants in the Lawsuit. 

 
 NOW THEREFORE, in consideration of the preceding recitals,
which are incorporated into and shall constitute terms and conditions of this Agreement, and the mutual promises and consideration set forth below, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows:

  
 DEFINITIONS 
  
 1. Definitions. The following terms, when used herein with initial capital letters,
shall have the meanings ascribed to them below. 
  
 a.
“Agreed Motion for Voluntary Dismissal” means the agreed motion to be filed in the Court of Appeals for the Seventh Circuit dismissing the Appeal with prejudice attached hereto as Exhibit C. 
  
 b. “Agreement” or “Settlement Agreement” shall have the
meaning first set forth in the introductory paragraph above. 
  

 2 

 c. “CA Claims” means any and all claims or controversies that Computer Associates has asserted
in the Lawsuit or could have asserted in the Lawsuit and that are based on or related to facts, circumstances or transactions asserted or discovered in the Lawsuit. 
  
 d. “CA Copyrights” means the following asserted Computer Associates’ copyright registrations for EDBA: Txu
1-028-946, TX 5-524-580, TX 5-524-581, TX 5-524-582, and TX 5-524-583 (which were attached as Exhibit 1 to Computer Associates’ First Amended Complaint). 
  

e. “CA Trade Secrets” means any trade secrets Computer Associates asserts are embedded in or contained within EDBA. 
  
 f. “Computer Associates” means Computer Associates International,
Inc., a Delaware corporation with its present principal place of business at One Computer Associates Plaza, Islandia, New York 11749, and any parent, subsidiary, division, member and/or affiliated entities, past or present, of any of the foregoing,
and any person or entity, past or present, acting on behalf of any of the foregoing, including, but not limited to, each of its respective present and former owners, shareholders, officers, executives, partners, directors, employees, attorneys,
agents and/or representatives. 
  
 g. “Defendants’
Counterclaims” means any counterclaim Defendants have asserted in the Lawsuit or could have asserted in the Lawsuit and that is based on or related to facts, circumstances or transactions asserted or discovered in the Lawsuit, including without
limitation the counterclaim asserted by Defendants in the Lawsuit seeking a declaratory judgment that the CA Copyrights are invalid and unenforceable. 
  
 h. “Dismissal Orders” means the Agreed Motion for Voluntary Dismissal and the Stipulation of Dismissal, collectively. 
  
 i. “EDBA” means any version of Computer Associates’ Enterprise
Database Administration program and associated object code and source code that existed on or before June 30, 1999. 
  
 j. “Effective Date” shall have the meaning first set forth in the introductory paragraph above. 
  
 k. “License Agreement” shall refer to the License Agreement
(attached as Exhibit A hereto) between Computer Associates and Quest Software, executed herewith. 
  
 l. “Quest Central for DB2” means the Quest Software product known as Quest Central for DB2, all alpha and beta versions thereof, versions 1.0
through 4.5 and all subsequent versions derived from such versions, and any other DB2 database management product that is derived from or contains the same source code or any portion thereof. 
  
 m. “Quest Software” means Quest Software, Inc., a California
corporation with its present principal place of business at 5 Polaris Way, Aliso Viejo, California 92656, and any parent, subsidiary, division, member and/or affiliated entities, past or present, of any of the foregoing, and any person or entity,
past or present, acting on behalf of any of the foregoing, 

  

 3 

 
including, but not limited to, each of its respective present and former owners, shareholders, officers, executives, partners, directors, employees,
attorneys, agents and/or representatives, excluding Friel, Mackowiak, Wahlgren, Bisotti and Jenson. 
  
 n. “Quest Software’s Customers” means any customer who had a license to, or who submitted a written order for a license to Quest Software
for, Quest Central for DB2 on or at any time before June 30, 2004. 
  
 o. “Stipulation of Dismissal” means the stipulation to be filed in the District Court dismissing with prejudice the CA Claims and the Defendants’ Counterclaims attached hereto as Exhibit B. 
  
 SETTLEMENT AGREEMENT AND MUTUAL RELEASE 
  
 2. Dismissal. 
  
 a. Computer Associates agrees to dismiss with prejudice the CA Claims by executing and providing to Quest Software’s
counsel of record this Agreement, the License Agreement and the Dismissal Orders. Defendants shall file the Dismissal Orders only pursuant to the requirements of subsection 2(d). 
  
 b. All Defendants agree to execute and provide to Computer Associates’ counsel of record this Agreement. 
  
 c. Quest Software agrees to execute and provide to Computer Associates’
counsel of record the License Agreement. 
  
 d. Defendants agree
to dismiss with prejudice Defendants’ Counterclaims and the Appeal by executing and filing the Dismissal Orders, but only after Quest Software’s counsel of record receives written notification from Computer Associates’ counsel of
record verifying Computer Associates’ receipt of the payment of $16,000,000.00 by Quest Software pursuant to Section 4(a) and Computer Associates’ receipt of the payment of $25,000.00 by Jenson pursuant to Section 4(b). 
  
 3. Releases; Waiver of Contribution and Indemnification; Limitations. 
  
 a. As of the Effective Date, Computer Associates shall, and does hereby,
release and forever discharge Quest Software and Quest Software’s Customers, Friel, Mackowiak, Wahlgren, Bisotti, and Jenson, and each of their heirs, executors, legal administrators, successors, and assigns, of and from any and all of the CA
Claims, except as limited in Section 3(d) herein. 
  
 b. As of the
Effective Date, Quest Software, Friel, Mackowiak, Wahlgren, Bisotti and Jenson, and each of their heirs, executors, legal administrators, successors, and assigns, shall, and do hereby, release and forever discharge Computer Associates of and from
any and all of the Defendants’ Counterclaims, except as limited in Section 3(d) herein. 
  

 4 

 c. As a material part of this Agreement, each Defendant agrees that this settlement has been entered into
in good faith and that all Defendants are discharged and forever released from any liability for any contribution to any other Defendant relating to the CA Claims. Further, each Defendant agrees to forever waive and not to seek any type of
indemnification or contribution from any other Defendant regarding the CA Claims or payments made hereunder. 
  
 d. The foregoing releases shall not release or discharge any claims or causes of action that arise after the Effective Date, including without limitation
breach of contract, copyright infringement, and trade secret misappropriation, that are based upon or arise out of a breach by any Party of any of the obligations undertaken or made pursuant to this Agreement or the License Agreement. 
  
 e. QUEST SOFTWARE ACKNOWLEDGES THAT IT HAS BEEN ADVISED BY LEGAL COUNSEL AND
IS FAMILIAR WITH THE PROVISIONS OF CALIFORNIA CIVIL CODE SECTION 1542, WHICH PROVIDES AS FOLLOWS: 
  
 “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE
RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS SETTLEMENT WITH THE DEBTOR.” 
  
 QUEST SOFTWARE, BEING AWARE OF SAID CODE SECTION, HEREBY EXPRESSLY WAIVES ANY RIGHTS IT MAY HAVE THEREUNDER AS WELL AS UNDER OTHER STATUTES OR COMMON LAW
PRINCIPLES OF SIMILAR EFFECT. 
  
 4. Payments. 
  
 a. By Quest Software. In consideration for this Agreement, Computer
Associates’ dismissal of the CA Claims and release of the Defendants (as set forth in Section 2(a) and Section 3(a), respectively), and in satisfaction of any and all damages allegedly suffered by Computer Associates as a result of the CA
Claims, Quest Software shall pay to Computer Associates the sum of sixteen million dollars ($16,000,000.00) within three (3) business days after the receipt by Quest Software’s counsel of record of this Agreement executed by all Parties
(including all Defendants), the License Agreement executed by Computer Associates and the Dismissal Orders executed by Computer Associates’ counsel of record. The sixteen million dollars ($16,000,000.00) shall be tendered via wire transfer
pursuant to the wiring instructions attached hereto as Exhibit D. If this payment is not made by Quest Software and received by Computer Associates according to the schedule just described, then this Agreement and the License Agreement shall be
rendered null, void, and of no effect ab initio, and the Parties shall have no obligations under them. 
  
 b. By Jenson. In consideration for this Agreement, Computer Associates’ dismissal of the CA Claims and release of Jenson (as set forth in
Section 2(a) and Section 3(a), respectively), and in satisfaction of any and all damages allegedly suffered by Computer Associates as a result of the CA Claims, Jenson shall pay to Computer Associates the sum of 

  

 5 

 
twenty-five thousand dollars ($25,000.00) within three (3) business days after the receipt by Quest Software’s counsel of record of this Agreement
executed by all Parties (including all Defendants), the License Agreement executed by Computer Associates and the Dismissal Orders executed by Computer Associates’ counsel of record. The twenty-five thousand dollars ($25,000.00) shall be
tendered in a cashier’s check by Jenson. 
  
 5. License by Computer
Associates. 
  
 a. As a condition to this Agreement, Computer
Associates and Quest Software shall enter into the License Agreement attached as Exhibit A. 
  
 b. Each Party expressly retains all rights not addressed either in this Agreement or the License Agreement. 
  
 6. Other Agreements of the Parties. 
  
 a. Other than as set forth in Section 5 of this Agreement and as more fully set forth in the attached License Agreement, Quest Software agrees not to
access, modify, use, copy, distribute, prepare derivative works of, market, sell, or offer to sell EDBA, the CA Copyrights, or CA Trade Secrets in the development of any products. 
  
 b. Friel, Mackowiak, Wahlgren, Bisotti and Jenson agree that they shall be, and hereby are, forever prohibited from
accessing, modifying, using, copying, distributing, preparing derivative works of, marketing, selling, or offering to sell EDBA, and otherwise performing any acts infringing the CA Copyrights or misappropriating CA Trade Secrets, except as permitted
by Section 6(c). 
  
 c. As long as any of the individual
Defendants are employed by Quest Software, those employees shall be entitled to exercise the license rights granted to Quest Software under the License Agreement. 
  
 d. Subject to Section 3(d) and Section 4(a), Computer Associates covenants and agrees that it will not bring suit against
any person or entity, including any current or former employee of Quest Software, for any CA Claims. 
  
 7. No Admissions. 
  
 Each
Party to this Agreement acknowledges and agrees that: (i) neither the execution of this Agreement nor the provision of a lump sum payment, any royalty payment or any other consideration provided for in this Agreement shall constitute, be construed
as, or be offered or received into evidence as, an admission of breach, default, fault or liability of any kind by any Party; (ii) this Agreement is entered into in compromise and settlement of disputed claims; and (iii) breach, default, fault and
liability are expressly denied by each Party. 
  
 8. Joint Press Release.

  
 Each Party agrees that upon the execution of this Agreement
and the License Agreement, Computer Associates and Quest Software will release the joint press release attached as Exhibit 

  

 6 

 
E. In the event that the rules or regulations of the SEC or any other government body require the filing of this Agreement or the License Agreement, or any
part of either of them, the filing Party will publicly file the entire Agreement or License Agreement, respectively. 
  
 9. Return of Material. 
  
 The Parties hereby reaffirm their obligation and intent to abide by the terms of Paragraph 15 of the February 6, 2003 Protective Order entered in this
Lawsuit by the Court (the “Protective Order”), which gives the Parties thirty (30) days after the termination of the Lawsuit to: 
  

	 	(i)	destroy or return to the disclosing party, or its attorney of record, the Confidential Information in their possession, custody, or control or in the possession, custody or control
of their staff; 

  

	 	(ii)	ensure that all Confidential Information in the possession, custody or control of their experts, is destroyed or returned to the disclosing Party, or its attorney of record;

  

	 	(iii)	destroy all notes, memoranda or other documents which contain excerpts from any of the Confidential Information; 

  

	 	(iv)	consent to the Court’s destruction of such Confidential Information, and if the Court is not willing to destroy such Confidential Information, then withdraw from the Court all
Confidential Information filed, lodged, or otherwise delivered to the Court under seal pursuant to Paragraph 9 of the Protective Order; and 

  

	 	(v)	notwithstanding anything in the Protective Order to the contrary, shall return source code to counsel for the Party disclosing the source code. 

  
 Notwithstanding any of the foregoing, any Party may retain copies of any
material filed with the Court, and Quest’s counsel of record may retain one copy of EDBA at its office to be used solely by a third-party expert to determine, in connection with the License Agreement, whether any Quest Software product should
be deemed to be a Royalty Product or a Bundled Royalty Product (as those terms are defined in the License Agreement). Quest Software intends to use Bruce Webster to assist it in proactively reviewing Quest Software’s products in light of EDBA,
which may require Webster to review the EDBA source code. Webster has agreed to continue to abide by the terms of the Protective Order entered in the Lawsuit. Computer Associates agrees that Webster is approved for the purposes of assisting Quest
Software in this regard, without Webster having to execute any additional documents. The Parties agree that the employment restrictions detailed in Section 5 of the Declaration Regarding Receipt of Confidential Information shall continue until one
(1) year after the retained expert returns to Quest Software’s counsel of record all whole or partial copies of EDBA. 
  
 If Quest Software desires to retain an expert other than Webster to review EDBA for any reason, each such expert must execute a confidentiality agreement
that contains the restrictions and obligations set forth in the Protective Order entered in the Lawsuit. The Parties agree that the employment restrictions detailed in Section 5 of the Declaration Regarding Receipt of Confidential Information shall
continue until one (1) year after the retained expert returns to 

  

 7 

 
Quest Software’s counsel of record all whole or partial copies of EDBA. Before any such expert is permitted access to the EDBA source code, the
following three conditions must be met: (1) such expert must be informed of the existence and contents of this Agreement and License Agreement; (2), the expert must be identified to Computer Associates and the confidentiality agreement signed by the
expert must be sent Computer Associates; and (3) Computer Associates will have ten (10) business days after receipt of the expert’s identity and signed confidentiality agreement to object in good faith, in writing, to disclosure of EDBA to such
expert; if such objection is made, the disclosure shall not be made until the objection is resolved in an arbitration proceeding to be initiated and conducted as provided under the License Agreement. The fee shifting provisions in Section 12.3 of
the License Agreement shall not apply to any arbitration initiated to resolve Computer Associate’s objections to an expert identified by Quest Software under this Section. 
  
 10. Representations and Warranties. 
  
 a. Each Party represents and warrants that the Party has the requisite power and authority and has taken all actions necessary to execute and deliver this
Agreement, to consummate the transactions contemplated hereby and to perform its, his or her obligations hereunder, and no other proceedings on their part are necessary to authorize this Agreement and the transactions contemplated hereby. The
individuals executing this Agreement and the agreements contemplated herein each represent and warrant that they have the required authority to bind the Party whom they purport to represent. If any additional acts are required to consummate the
transactions contemplated hereby or to perform any Party’s obligations hereunder, each Party covenants in good faith to perform such additional acts and execute any necessary documents as may be reasonably necessary to give effect to the terms
of this Agreement. 
  
 b. Computer Associates and Quest Software,
Friel, Mackowiak, Wahlgren, Bisotti and Jenson each represent and warrant that they now hold all right, title to, and interest in any and all of the claims it is releasing hereunder (“Released Claims”), and that they have not assigned or
otherwise transferred any right, title, or interest in any Released Claims, and each Party hereby agrees to forever indemnify and hold forever harmless each other Party from all Released Claims, including, but not limited to, attorneys’ and
expert fees, incurred as a result of any person or entity asserting any such Released Claims against such other Party pursuant to any such assignment or transfer. 
  
 c. Quest Software represents and warrants to Computer Associates that: (i) Quest Software’s products, including, but
not limited to, Quest Central for Oracle, Quest Central for SQL Server, and Quest Central for Sybase, but excluding Quest Central for DB2, do not infringe the CA Copyrights or misappropriate the CA Trade Secrets; and (ii) Quest Software is not
funding the payment being made by Jenson under Section 4. 
  
 d.
Except for the portions of EDBA that comprise the Licensed Source Code, Quest Software represents and warrants to Computer Associates that, based on a good faith investigation: (i) Quest Software does not believe it has in its possession, custody,
or control any copies of EDBA, except those copies retained by Quest Software’s counsel of record or outside retained experts in the Lawsuit; and (ii) Quest Software will not use EDBA after the Effective 

  

 8 

 
Date. If Quest Software later becomes aware of any whole or partial copies of EDBA in any form, except those copies retained by Quest Software’s counsel
of record or experts retained under Section 9, in the possession, custody, or control of Quest Software or any of its employees, agents, or representatives, Quest Software must: (i) provide Computer Associates with prompt notice of such fact,
including the names of any individual who possessed the copy of EDBA or parts thereof; (ii) any use made of EDBA; and (iii) immediately return the copy of EDBA or any part thereof to Computer Associates. 
  
 e. Each Party represents that in executing this Agreement it is relying
solely on its own judgment, belief, and knowledge and upon the advice and recommendation of its counsel concerning the nature, extent, and duration of its rights and obligations deriving from this Agreement. 
  
 f. Each Party acknowledges that at no time has any individual or entity made
any representations, promises, or statements (whether oral or written) regarding the matters addressed herein to any other Party except as set forth in this Agreement. Each Party warrants and represents that it has not been induced to enter into
this Agreement on the basis of any other representations, promises, or statements (whether oral or written) made by any Party at any time. 
  
 g. Jenson represents and warrants to Computer Associates that she is making the payment in Section 4 from her personal funds. 
  
 11. Competitive products. 
  
 Except as expressly provided for in the License Agreement limiting Quest
Software’s rights regarding the Licensed Source Code for specific purposes, nothing in this Agreement or the License Agreement shall be interpreted as prohibiting or limiting in any way any Party’s right to make, use, copy, distribute,
market, sell, or offer to sell any product competing directly or indirectly with any other Party’s product. Nothing in this Agreement or the License Agreement shall be interpreted as prohibiting or limiting in any way a Party’s right to
pursue against any other Party any claim it may have that is not released in this Agreement. 
  
 12. Waiver. 
  
 No waiver
of any term, provision, or condition of this Agreement, whether by conduct or otherwise, shall be deemed, or be construed, as a further or continuing waiver of any such term, provision or condition or as a waiver of any other term, provision, or
condition of this Agreement. 
  
 13. Interpretation. 
  
 This Agreement shall be interpreted simply and fairly and not strictly in
favor of or against any Party. To this end, the Parties agree that the terms and conditions of this Agreement are the product of an arm’s length negotiation. The Parties intend that each representation, warrant, and covenant contained herein
shall have independent significance. If any Party has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty, or covenant relating to the same subject matter
(regardless of the relative levels of specificity) that the Party has not breached shall not detract 

  

 9 

 
from or mitigate the fact that the Party is in breach of the first representation, warranty, or covenant. 
  
 14. Governing Law. 
  
 This Agreement shall be construed and governed in accordance with the laws of the State of Illinois, and with respect only
to Section 3(d), the State of California. 
  
 15. Jurisdiction. 

 
 The Parties agree that venue for all disputes arising out of this
Agreement shall lie in the United States District Court for the Northern District of Illinois. Each Party hereby irrevocably and unconditionally: (a) consents to the jurisdiction of that court in any such dispute; and (b) waives any objection which
such Party may have to the laying of venue of any such dispute in that court. In the event the United States District Court for the Northern District of Illinois lacks or declines jurisdiction over any dispute relating to the enforcement and/or
interpretation of this Agreement then any such litigation shall be brought in the state court in Illinois, in the County of DuPage or Cook at the discretion of the Party initiating such litigation, and the Parties hereto expressly consent to the
jurisdiction of that court and waive any objection thereto. 
  
 16.
Injunction. 
  
 In the event that any Party is successful
either in proving the breach of this Agreement or in demonstrating a likelihood of prevailing in an action for breach of this Agreement, the Parties agree that monetary damages are inadequate compensation and that such Party is entitled to
injunctive relief. 
  
 17. Attorneys’ Fees. 
  
 In the event of a dispute between the parties or of any breach or default
under this Agreement, the party prevailing in the resolution of any such dispute, breach, or default shall be entitled to recover its reasonable attorneys’ fees and other costs incurred in connection with resolving such dispute, breach, or
default. 
  
 18. Costs And Expenses. 
  
 All costs and expenses incurred in the Lawsuit and Appeal with regard to the
CA Claims and Defendants’ Counterclaims, including any attorneys’ fees and expert witness fees, shall be paid by the Party incurring such costs or expenses. 
  
 19. Successors And Assigns. 
  
 a. This Agreement may not be assigned or transferred by Quest Software without the prior written consent of Computer Associates, except that Quest
Software shall have the right to assign this Agreement (i) to an affiliate or subsidiary of Quest Software, (ii) to any successor in a merger or acquisition of Quest Software or (iii) to an entity that acquires all or substantially all of the assets
of a business unit of Quest Software of which Quest Central for DB2 is one such asset. 

  

 10 

 
Notwithstanding any of the foregoing, Quest Software is prohibited from assigning its payment obligations under Section 4 of this Agreement. 
  
 b. The obligations and duties of this Agreement shall be binding upon the
Parties, their successors, and assigns, and the rights of this Agreement shall inure to the benefit of permitted successors and assigns. 
  
 20. Severability. 
  
 If any clause or provision of this Agreement is declared illegal, invalid, or unenforceable under present or future laws effective during the term hereof,
it is the intention of the Parties hereto to reach agreement to terms that will lawfully carry out the intended purpose of any such clause or provision, and to take such action as may be necessary to do so. The Parties further intend that the
remainder of this Agreement shall not be affected thereby, and shall remain in full force and effect. 
  
 21. Notices. 
  
 Any
notices required by this Agreement shall be in writing, and shall specifically refer to this Agreement and shall be sent by registered or certified mail, postage prepaid, or by first class U.S. Mail, postage prepaid, or by confirmed facsimile, or by
overnight courier, postage prepaid, and shall be forwarded to the respective addresses set forth below unless subsequently changed by written notice to the other Party: 
  

			
	For COMPUTER ASSOCIATES:	  	Kenneth V. Handal
	 	  	Executive Vice President, General Counsel
	 	  	Computer Associates International, Inc.
	 	  	One Computer Associates Plaza
	 	  	Islandia, NY 11749
	 	  	Fax: 631-342-4866
		
	 For Quest
 Software:
	  	J. Michael Vaughn
	 	  	General Counsel
	 	  	Quest Software, Inc.
	 	  	5 Polaris Way
	 	  	Aliso Viejo, CA 92656
	 	  	Fax: 949-754-8977
		
	For Michael Friel:	  	 Michael Friel
 14610 Raneys Lane
 Orland Park, IL 60462

  

 11 

			
	For Debra Jenson:	  	 Debra Jenson
 39w359 Silver Glen Road
 St. Charles, IL 60175

		
	For Elizabeth Wahlgren:	  	 Elizabeth Wahlgren
 523 E. Indiana St.
 Wheaton, IL 60187

		
	For Robert Mackowiak:	  	 Robert Mackowiak
 4320 Esquire Cir.
 Naperville IL 60564

		
	For Frank Bisotti:	  	 Frank Bisotti
 5112 20th Ave
 Kenosha, WI 53140

  
 Notice shall be deemed
delivered upon the earliest to occur of: (i) when received; (ii) three (3) days after deposit into the United States mail, first class with postage prepaid; (iii) the date notice is sent via confirmed facsimile; and (iv) the day immediately
following confirmed delivery by overnight courier (except Sundays and holidays). 
  
 22. Final Agreement. 
  
 This Agreement together
with all exhibits hereto (which are incorporated herein by this reference) are the complete, final, and exclusive statement of the Agreement between the Parties with respect to the subject matter hereof. This Agreement supersedes all prior or
contemporaneous agreements, negotiations, representations, understandings, and discussions between the Parties and/or their respective counsel with respect to the subject matter covered hereby. Any modification, alteration, or amendment of this
Agreement shall be void and have no force or effect unless it is in writing and signed by the Party sought to be charged. 
  
 23. Execution in Counterparts; Facsimile Signatures. 
  
 This Agreement may be executed in counterparts. Each of said counterparts, when so executed and delivered, shall be deemed an original and, taken
together, shall constitute but one and the same instrument. For purposes of the execution of this Agreement, signature pages transmitted by facsimile shall be given the same weight and effect as, and treated as, original signatures. 
  

									
	 	 	 	 	 Computer Associates International, Inc.

					
	DATED:	 	March     , 2005	 	 	 	By:	 	 
	 	 	 	 	 	 	 Print Name:
	 	 
	 	 	 	 	 	 	Position:	 	 

  
  

 12 

									
	 	 	 	 	 Quest Software, Inc.

					
	DATED:	 	March     , 2005	 	 	 	By:	 	 
	 	 	 	 	 	 	 Print Name:
	 	 Douglas F. Garn

	 	 	 	 	 	 	Position:	 	 President

				
	DATED:	 	March     , 2005	 	 	 	Michael J. Friel

  
 The foregoing
instrument was acknowledged before me this      day of             , 2005, by Michael J. Friel. He is personally known to me. 
  
 Notary Public, State of
                         
 Printed name: 
  
 (NOTARY SEAL) 
  

							
	DATED:	 	March     , 2005	 	 Robert M. Mackowiak

			
	 	 	 	 	 

  
 The foregoing
instrument was acknowledged before me this      day of             , 2005, by Robert M. Mackowiak. He is personally known to me. 
  
 Notary Public, State of
                         
 Printed name: 
  
 (NOTARY SEAL) 
  

							
	DATED:	 	March     , 2005	 	 Elizabeth W. Wahlgren

			
	 	 	 	 	 

  
 The foregoing
instrument was acknowledged before me this      day of             , 2005, by Elizabeth W. Wahlgren. She is personally known to me. 
  
 Notary Public, State of
                         
 Printed name: 
  
 (NOTARY SEAL) 
  

							
	DATED:	 	March     , 2005	 	 Frank L. Bisotti

			
	 	 	 	 	 

  
  
  

 13 

 The foregoing instrument was acknowledged before me this      day of
            , 2005, by Frank L. Bisotti. He is personally known to me. 
  
 Notary Public, State of
                         
 Printed name: 
  
 (NOTARY SEAL) 
  

							
	DATED:	 	March     , 2005	 	 Debra A. Jenson

			
	 	 	 	 	 

  
 The foregoing
instrument was acknowledged before me this      day of             , 2005, by Debra A. Jenson. She is personally known to me. 
  
 Notary Public, State of
                         
 Printed name: 
  
 (NOTARY SEAL) 
  
  
  

 14 

 EXHIBIT A—LICENSE AGREEMENT 
  
  

 15 

 EXHIBIT B—STIPULATION OF DISMISSAL 
  
  

 16 

 EXHIBIT C—AGREED MOTION FOR VOLUNTARY DISMISSAL 
  
  

 17 

 EXHIBIT D—WIRE INSTRUCTIONS 
  
  

 18 

 EXHIBIT E—JOINT PRESS RELEASE 
  

 19

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00084-of-00352.parquet"}]]